#62025CC0312EU Advocate General Opinion on JSIS Contributions and Fertility Treatment Coverage
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This opinion examines whether an EU official can challenge salary statements that show contributions to the EU’s Joint Sickness Insurance Scheme after the scheme was expanded to reimburse some medically assisted reproduction costs, including treatments not linked to an illness. The practical issue is standing: whether an unchanged insurance contribution can still be challenged because the official objects to how the scheme uses the money. The case matters mainly for EU staff, EU institutions, and administrators of the EU staff health insurance system.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Examines whether EU officials have standing to challenge salary statements linked to JSIS contributions.
- Focuses on JSIS coverage for medically assisted reproduction, including treatment not tied to illness.
- Raises whether an unchanged contribution rate can still harm an official’s financial or non-material interests.
Obligations
What this law requires
EU officials are required under the EU Staff Regulations to contribute to the Joint Sickness Insurance Scheme for sickness insurance coverage.
The Joint Sickness Insurance Scheme was extended in 2023 to reimburse part of the costs of medically assisted reproduction, including treatments whether or not linked to a pathology.
The General Court held that salary statements showing an unchanged JSIS contribution rate did not constitute an act adversely affecting the official for purposes of standing in this challenge.